Top

Published in:

01-04-2017 | Topic Paper

Lymph node dissection in bladder cancer: Where do we stand?

Authors: Cory M. Hugen, Siamak Daneshmand

Published in: World Journal of Urology | Issue 4/2017

Abstract

Radical cystectomy with lymphadenectomy remains the standard-of-care treatment for muscle-invasive bladder cancer. Lymphadenectomy is a central component of the operation because it continues to play both diagnostic and therapeutic roles. Routinely available preoperative imaging has limited diagnostic accuracy as it relies mostly on size to identify nodal metastasis increasing the value of lymphadenectomy. While the merits of lymphadenectomy are not in question, the extent of lymphadenectomy required to provide maximum benefit while limiting morbidity remains controversial. Furthermore, although robotic-assisted surgery has gained popularity in many centers, concern remains regarding the learning curve required and skill needed to replicate the quality of an open lymphadenectomy. Research efforts have been focused on these unresolved issues, and several trials are currently ongoing to help address these knowledge deficit areas. In this update, we will focus on the current state of lymphadenectomy for bladder cancer and highlight recent advances.

Zehnder P, Studer UE, Skinner EC, Thalmann GN, Miranda G, Roth B et al (2013) Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades. BJU Int 112(2):E51–E58CrossRefPubMed

Stein JP, Quek ML, Skinner DG (2006) Lymphadenectomy for invasive bladder cancer: I. historical perspective and contemporary rationale. BJU Int 97(2):227–231CrossRefPubMed

Kerr WS, Colby FH (1950) Pelvic lymphadenectomy and total cystectomy in the treatment of carcinoma of the bladder. J Urol 63:842

Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S et al (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19(3):666–675CrossRefPubMed

Zehnder P, Studer UE, Daneshmand S, Birkhauser FD, Skinner EC, Roth B et al (2014) Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy. BJU Int 113(4):554–560CrossRefPubMed

Hedgepeth RC, Zhang Y, Skolarus TA, Hollenbeck BK (2011) Variation in use of lymph node dissection during radical cystectomy for bladder cancer. Urology 77(2):385–390CrossRefPubMed

Mata DA, Groshen S, Von Rundstedt FC, Skinner DG, Stadler WM, Cote RJ et al (2015) Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder. J Surg Oncol 111(7):923–928CrossRefPubMedPubMedCentral

Cole AP, Dalela D, Hanske J, Mullane SA, Choueiri TK, Meyer CP et al (2015) Temporal trends in receipt of adequate lymphadenectomy in bladder cancer 1988 to 2010. Urol Oncol 33:504CrossRefPubMed

Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE (2008) Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 179(3):873–878 (discussion 878) CrossRefPubMed

10.

Zehnder P, Studer UE, Skinner EC, Dorin RP, Cai J, Roth B et al (2011) Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol 186(4):1261–1268CrossRefPubMed

11.

Bruins HM, Veskimae E, Hernandez V, Imamura M, Neuberger MM, Dahm P et al (2014) The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review. Eur Urol 66(6):1065–1077CrossRefPubMed

12.

Herr HW, Faulkner JR, Grossman HB, Natale RB, deVere White R, Sarosdy MF et al (2004) Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 22(14):2781–2789CrossRefPubMed

13.

Leissner J, Ghoneim MA, Abol-Enein H, Thuroff JW, Franzaring L, Fisch M et al (2004) Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 171(1):139–144CrossRefPubMed

14.

Dangle PP, Gong MC, Bahnson RR, Pohar KS (2010) How do commonly performed lymphadenectomy templates influence bladder cancer nodal stage? J Urol 183(2):499–503CrossRefPubMed

15.

Simone G, Papalia R, Ferriero M, Guaglianone S, Castelli E, Collura D et al (2013) Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy. Int J Urol 20(4):390–397CrossRefPubMed

16.

Shariat SF, Ehdaie B, Rink M, Cha EK, Svatek RS, Chromecki TF et al (2012) Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment. Eur Urol 61(2):237–242CrossRefPubMed

17.

Bruins HM, Skinner EC, Dorin RP, Ahmadi H, Djaladat H, Miranda G et al (2014) Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non-muscle invasive bladder cancer: results from a prospective lymph node mapping study. Urol Oncol 32(1):24.e13–24.e19CrossRef

18.

Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF (2002) Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167(3):1295–1298CrossRefPubMed

19.

Leissner J, Hohenfellner R, Thuroff JW, Wolf HK (2000) Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 85(7):817–823CrossRefPubMed

20.

Rink M, Shariat SF, Xylinas E, Fitzgerald JP, Hansen J, Green DA et al (2012) Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy? World J Urol 30(6):807–814CrossRefPubMed

21.

Zehnder P, Moltzahn F, Mitra AP, Cai J, Miranda G, Skinner EC et al (2014) Radical cystectomy with super-extended lymphadenectomy: impact of separate vs en bloc lymph node submission on analysis and outcomes. BJU Int. doi:10.1111/bju.12956

22.

Dorin RP, Daneshmand S, Eisenberg MS, Chandrasoma S, Cai J, Miranda G et al (2011) Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study. Eur Urol 60(5):946–952CrossRefPubMed

23.

Stein JP, Cai J, Groshen S, Skinner DG (2003) Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol 170(1):35–41CrossRefPubMed

24.

Karl A, Carroll PR, Gschwend JE, Knuchel R, Montorsi F, Stief CG et al (2009) The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol 55(4):826–835CrossRefPubMed

25.

Yuh BE, Nazmy M, Ruel NH, Jankowski JT, Menchaca AR, Torrey RR et al (2012) Standardized analysis of frequency and severity of complications after robot-assisted radical cystectomy. Eur Urol 62(5):806–813CrossRefPubMed

26.

Mmeje CO, Nunez-Nateras R, Nielsen ME, Pruthi RS, Smith A, Wallen EM et al (2013) Oncologic outcomes for lymph node-positive urothelial carcinoma patients treated with robot assisted radical cystectomy: with mean follow-up of 3.5 years. Urol Oncol 31(8):1621–1627CrossRefPubMed

27.

Davis JW, Gaston K, Anderson R, Dinney CP, Grossman HB, Munsell MF et al (2011) Robot assisted extended pelvic lymphadenectomy at radical cystectomy: lymph node yield compared with second look open dissection. J Urol 185(1):79–83CrossRefPubMed

28.

Raza SJ, Wilson T, Peabody JO, Wiklund P, Scherr DS, Al-Daghmin A et al (2015) Long-term oncologic outcomes following robot-assisted radical cystectomy: results from the international robotic cystectomy consortium. Eur Urol 68(4):721–8CrossRefPubMed

29.

Vargas HA, Akin O, Schoder H, Olgac S, Dalbagni G, Hricak H et al (2012) Prospective evaluation of MRI, (1)(1)C-acetate PET/CT and contrast-enhanced CT for staging of bladder cancer. Eur J Radiol 81(12):4131–4137CrossRefPubMed

30.

Birkhauser FD, Studer UE, Froehlich JM, Triantafyllou M, Bains LJ, Petralia G et al (2013) Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer. Eur Urol 64(6):953–960CrossRefPubMed

31.

Kibel AS, Dehdashti F, Katz MD, Klim AP, Grubb RL, Humphrey PA et al (2009) Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol 27(26):4314–4320CrossRefPubMedPubMedCentral

32.

Goodfellow H, Viney Z, Hughes P, Rankin S, Rottenberg G, Hughes S et al (2014) Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer. BJU Int 114(3):389–395PubMed

33.

Picchio M, Treiber U, Beer AJ, Metz S, Bossner P, van Randenborgh H et al (2006) Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings. J Nucl Med 47(6):938–944PubMed

34.

Tilki D, Brausi M, Colombo R, Evans CP, Fradet Y, Fritsche HM et al (2013) Lymphadenectomy for bladder cancer at the time of radical cystectomy. Eur Urol 64(2):266–276CrossRefPubMed

Title: Lymph node dissection in bladder cancer: Where do we stand?
Authors: Cory M. Hugen
Siamak Daneshmand
Publication date: 01-04-2017
Publisher: Springer Berlin Heidelberg
Published in: World Journal of Urology / Issue 4/2017
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-015-1751-9

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Lymph node dissection in bladder cancer: Where do we stand?

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2017

Re: Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study

Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients

Genetic variants in RNA-induced silencing complex genes and prostate cancer

Current impact of age and comorbidity assessment on prostate cancer treatment choice and over/undertreatment risk

PET imaging for lymph node dissection in prostate cancer

Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma